Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05076604Phase 4Completed
Phase 4, randomised, double-blind trial in aortic valve disease (AVD) and mitral valve disease, sponsored by Washington University School of Medicine. Primary endpoint: Intraoperative and Postoperative Red Blood Cell Transfusion Rates at 30 days. Started Mar 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05076604.